BR112016006664A2 - compostos para a inibição do crescimento celular desregulado - Google Patents
compostos para a inibição do crescimento celular desreguladoInfo
- Publication number
- BR112016006664A2 BR112016006664A2 BR112016006664A BR112016006664A BR112016006664A2 BR 112016006664 A2 BR112016006664 A2 BR 112016006664A2 BR 112016006664 A BR112016006664 A BR 112016006664A BR 112016006664 A BR112016006664 A BR 112016006664A BR 112016006664 A2 BR112016006664 A2 BR 112016006664A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- cell growth
- inhibition
- unregulated cell
- unregulated
- Prior art date
Links
- 230000010261 cell growth Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000005764 inhibitory process Effects 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000622 WO2015044960A2 (en) | 2013-09-26 | 2014-09-26 | Compounds for inhibition of unregulated cell growth |
| IN3015MU2013 IN2013MU03015A (OSRAM) | 2013-09-26 | 2014-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016006664A2 true BR112016006664A2 (pt) | 2017-08-01 |
Family
ID=52744636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016006664A BR112016006664A2 (pt) | 2013-09-26 | 2014-09-26 | compostos para a inibição do crescimento celular desregulado |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160214941A1 (OSRAM) |
| EP (1) | EP3049083A4 (OSRAM) |
| JP (1) | JP2017506617A (OSRAM) |
| BR (1) | BR112016006664A2 (OSRAM) |
| CA (1) | CA2925218A1 (OSRAM) |
| IL (1) | IL244730A0 (OSRAM) |
| IN (1) | IN2013MU03015A (OSRAM) |
| WO (1) | WO2015044960A2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3626703A4 (en) * | 2017-05-16 | 2020-12-16 | Industry-Academic Cooperation Foundation, Yonsei University | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THIS AS AN ACTIVE SUBSTANCE |
| CN113061118B (zh) * | 2021-04-08 | 2022-05-27 | 株洲九派科技发展有限公司 | 一种吩嗪-查尔酮杂合化合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6767919B2 (en) * | 2002-12-17 | 2004-07-27 | Walker Cancer Research Institute, Inc. | High specificity anticancer agents |
| US6821983B2 (en) * | 2003-04-04 | 2004-11-23 | Academia Sinica | 5-(9-acridinylamino)-toluidine compounds |
| WO2008135886A2 (en) * | 2007-05-02 | 2008-11-13 | University Of Pretoria | Quinoline derivatives for use in the inhibition of the growth of tumour cells |
-
2014
- 2014-09-26 WO PCT/IN2014/000622 patent/WO2015044960A2/en active Application Filing
- 2014-09-26 JP JP2016517547A patent/JP2017506617A/ja active Pending
- 2014-09-26 BR BR112016006664A patent/BR112016006664A2/pt not_active Application Discontinuation
- 2014-09-26 US US15/024,980 patent/US20160214941A1/en not_active Abandoned
- 2014-09-26 EP EP14849098.0A patent/EP3049083A4/en not_active Withdrawn
- 2014-09-26 CA CA2925218A patent/CA2925218A1/en active Pending
- 2014-09-26 IN IN3015MU2013 patent/IN2013MU03015A/en unknown
-
2016
- 2016-03-23 IL IL244730A patent/IL244730A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3049083A2 (en) | 2016-08-03 |
| IL244730A0 (en) | 2016-04-21 |
| EP3049083A4 (en) | 2017-11-22 |
| JP2017506617A (ja) | 2017-03-09 |
| CA2925218A1 (en) | 2015-04-02 |
| US20160214941A1 (en) | 2016-07-28 |
| IN2013MU03015A (OSRAM) | 2015-07-17 |
| WO2015044960A3 (en) | 2017-01-19 |
| WO2015044960A2 (en) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
| UY34445A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| EA201690473A1 (ru) | Комбинированный состав двух противовирусных соединений | |
| MX2018003130A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas a receptor de interleucina-1 (irak) y usos de los mismos. | |
| UA110338C2 (xx) | Хімічні сполуки | |
| PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
| CR20210079A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| CR20130470A (es) | INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA | |
| EA201691625A1 (ru) | Ароматические гетероциклические соединения как противовоспалительные соединения | |
| EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
| CR20140306A (es) | Fluormetil -5,6-dihidro-4h-[1,3] oxazinas | |
| CR20140495A (es) | 5-amino[1,4]thiazines como inhibidores de bace1 | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| CR20150417A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| UA113086C2 (xx) | Піразольні сполуки як інгібітори sglt1 | |
| MX2018003903A (es) | Compuesto biciclico y uso del mismo para inhibicion de suv39h2. | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| AR124083A2 (es) | Nuevo inhibidor de sglt1 | |
| IN2013DE02503A (OSRAM) | ||
| BR112016006664A2 (pt) | compostos para a inibição do crescimento celular desregulado | |
| DK201300179U1 (da) | Kemisk forbindelse med nyttige egenskaber | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| DOP2017000070A (es) | Inhibidores cristalinos de bace | |
| EA201690593A1 (ru) | Новые соединения мочевины |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |